Babies Learn Music While Sleeping
Early screening and treatment for infants with hearing problems, and the ability to computer-generate musical scores, are two very different possible outcomes of some "off-the-wall" research.
Brussels, Belgium (PRWEB) February 23, 2009 -- Babies learn music wh...
Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
Even Among Companies Doing Well, Relationships Weaken in Many Countries
NEW YORK, Feb. 17 /PRNewswire/ -- New TNS Healthcare research shows that physicians in four out of the five major European countries -- the UK, Germany, Spain and Italy -- give Novartis top marks for effectively deliverin...
M. D. Anderson Automates Laboratory Workflow with Stone Bond Technologies : EE-LIMS™ from Stone Bond Technologies Will Document Activities within the Laboratory Workflow at the siRNA Facility, Increasing Throughput, While Reducing Risks
The newly established Small Interfering Ribonucleic Acid (siRNA) Facility at M. D. Anderson Cancer Center has been charged with providing high-quality siRNA screening services for both internal and external customers.
HOUSTON (Business Wire EON) July 1, 2008 -- M. D. ...
Northeastern University and Mass General Hospital Increase the Accuracy, While Reducing the Diagnosis Time, for Breast Cancer Detection
Research teams solve the computational hurdle using Star-P
WALTHAM, Mass., Feb. 26 /PRNewswire/ -- Researchers at the Northeastern
University Computer Architecture Research Lab (NUCAR) and the National
Science Foundation's (NSF) Center for Subsurface Sensing and Imaging
Secure Symbology: Making New Jersey Proud While Saving Lives
WAYNE, N.J., Oct. 9 /PRNewswire/ -- A homegrown New Jersey company is
earning accolades for its anti-counterfeiting technology that safeguards
the pedigree of pharmaceuticals everywhere. Secure Symbology
(http://www.securesymbology.com ), a Wayne, NJ based company has been chosen as an
Save money while your data grows
Not all data is created equal. Information lifecycle management, a fresh concept in data storage technology, suggests data should be be categorized and placed them into tiers associated with different costs and performance capabilities. For example, wide ranges of data, from customer orders to pict...
Biotech flourishes in 2005 while Big Pharma is on the decline
Goodbye, 2005, and hello, 2006! I sit hear writing this article as I listen, appropriately, to a new Cream anthology album called "Cream Gold" (released in 2005 - not to be confused with the live Cream concerts held in 2005). Why Cream, you may ask? Well, the successful re-emergence of this super...
U.S. VC funding flat in 2005 while life science funding grows
As the topic of financing is vital to a biotech company (it is priority #1, #2, and #3) and biotech (and I use "biotech" in the broadest sense) companies are continually faced with the challenge of raising money due to the long product development cycle, this week's article will focus on venture ...
Madison is flourishing while Marinette is dying
M adison, Wis. - I am a northern Wisconsin boy - Marinette County. My hometown, Marinette, has lost over 30 percent of its population since I grew up there in the 1950s and 1960s. Why?
It can be summed up in three words: young people's decisions. Local columnist John Roach once told me ...
CIOs focus on the business case while facing 'authority erosion'
Leslie Hearn Madison, Wis. - The total cost of ownership often is overlooked when making the business case for a software implementation, but it might just be the key factor for chief technologists who are defending their turf.
The ability to establish and continually re-evaluate the busine...
State tax compromises prove that partisanship can be set aside for a while
Madison, Wis . - The average citizen may think Gov. Jim Doyle and the Republican-led Legislature fight like Ali and Frazier whenever they step into the boxing ring of politics. And judging by some of the bare-knuckled debates that have taken place in the Capitol over the past two and a half year...
...rystals in solution with subnanometer resolution. Their results showed that while
some crystals in solution grow steadily in size via classical nucleation an...ire a much better understanding of colloidal nanocrystal growth mechanisms. while
the past two decades have seen tremendous advances in the synthesis of semi...
SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
...and development expenses to our ibuprofen and pseudoephedrine lead products while
also supporting our existing alliances. We have made significant reductions...YSE Amex that we are not in compliance with continued listing requirements. while
we have provided the NYSE Amex with a plan to regain compliance with applic...
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
...hich we will discuss in detail as they are developed. We are encouraged in that regard by renewed investors' appetite for investing in our industry. while
there can be no assurance, we hope, if we obtain positive results from the analysis of our trial data, that we will be able to attract new capital fro...
NeurogesX Reports Second Quarter 2009 Results
...advanced our progression into a commercial company while
finalizing our partnership with Astellas fulfilled...in this program late this year or early next year. while
we are comfortable with our current financial situ...nificantly less liver toxicity than acetaminophen, while
additional data demonstrated the production of equ...
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
...orts filed with the SEC. VGV-1 is not approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world. while
Viral Genetics believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could ...
ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA
...y research immunoassay kits. Since that time, their primary goals have been to offer a diverse line of assays that appeal to their broad customer base while
also providing exceptional customer service and product support. In recent years, ALPCO has solidified its place in the market not only as a distribut...
Microbix Sales Grow 22% For Nine Months
...c we acquired in September 2008. We purchased the Urokinase inventory on the premise that it was stable and releasable under an FDA approvable letter. while
the FDA has conceded the data we presented has merit, at a recent meeting of appeal the FDA requested yet more stability data before they will reconsi...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... in percent predicted FVC at Week 72 and secondary endpoints of progression-free survival and categorical change in percent predicted FVC.
CAPACITY 1 did not achieve statistical significance on the primary endpoint at Week 72, the results were generally consistent with and supportive of C...
Ratcliff Adds Architect John Sealander to Healthcare Practice Group
...healthcare, academic, and civic clients throughout the Western United States.
A licensed architect in California, Sealander was Project Manager while
at Stantec Architecture for the Ryan Ranch Outpatient Campus for the Community Hospital of the Monterey Peninsula which received an American Institute...
PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan
...re Alzheimer's disease and cognitive aging.
The journey began when Frank Longo, M.D., Ph.D., began receiving funding from ADDF eight years ago while
at UCSF (and then later at University of North Carolina) to find small molecules with the features of large biological agents that could both effectiv...
Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
to pharmaceutical partners for sales and marketing.
Debiopharm independently funds the worldwide development of all of its
providing expertise in pre-clinical and clinical trials,
manufacturing, drug delivery and formulation, and regulatory affairs.
Founded in 1979 ...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
... are designed to catch clot material to prevent it from reaching the lungs, while
allowing blood to continue to flow normally. Patients at high risk for pulm...nable thinner stent struts, increased flexibility and a lower stent profile while
improving radial strength, recoil and radiopacity. In addition, the TAXUS E...
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
... addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while
supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Add...
The Breast Cancer Therapeutics Market in Australia
... targeted therapies as effective forms of cancer therapy is becoming more prevalent. These therapies are specifically designed to target cancer cells, while
minimizing the adverse effects on normal cells when compared to cytotoxic chemotherapeutic drugs. New offerings must constitute therapies that will im...
PDI Reports 2009 Second Quarter Financial Results
...egically align the business units to be profitable while
adding new, high quality personnel with the experi...ources. This further expands our product offerings while
leveraging our core abilities.
"In addition...ears to come.
"Finally, I want to note that while
we have begun to benefit from the pharmaceutical i...
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... also reimburses worldwide development costs on a 50/50 basis, and in return Shire received rights to commercialize these products outside of the U.S. while
Amicus retains all rights to commercialize these products in the U.S. In addition, Amicus leads development operations through the end of Phase 2 clin...
AIAG and MichBio Form New Collaborative Partnership
...utomotive industry and diversify into the exploding medical devices market. while
the automotive market has been on a decline, the medical device industry is...ions for medical care from patients, and advances in medical technologies. while
many synergies exist, some retooling will most likely be required. However,...
CapitalBio Corporation and VigeneTech Inc. Have Announced the Launch of a Fully Integrated Microarray Solution Platform
...sensitivity, and image data of superior accuracy. VigeneTech's customized quality control processes and flexible architecture ensure robust automation while
maintaining the flexibility to meet the quality and performance demands of clinical and pre-clinical array applications.
"The MicroVigene softw...
Knighted Adds Industry Pioneer and Entrepreneur to Senior Management Team
...ly unlimited potential," said Mr. Wilensky. "Over the past 15 years, Knighted has built arguably the most dynamic software for managing supply chains while
processing billions of inventory transactions each year for Fortune 1,000 companies. Knighted founder & CEO Daniel Napoli's visionary approach to...
BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing
...e to iron and steel. As confirmed by this independent test, Ygiene(TM) Hospital Grade Antimicrobial was found to be completely inert and not corrosive while
all of the following products tested were found to be corrosive: Lysol(R) Disinfectant All Purpose Cleaner 4N1; Odo Ban(R) Silver Formula Germ Control...
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
...provement on several secondary endpoints at 12 months, and at 18 months, a statistically significant treatment effect on the primary endpoint emerged, while
several additional secondary endpoints also showed improvement. In contrast, on no measure did sham patients perform better than CERE-120 patients, at...
NxStage Reports Second Quarter 2009 Financial Results
...e date of this press release. NxStage anticipates that subsequent events and developments may cause these expectations and beliefs to change. However, while
NxStage may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, whether a...
Saint-Gobain Introduces Next Generation Silicone Tubing
... with new Sani-Tech(R) Ultra. This platinum-cured silicone tubing meets the stringent requirements of demanding biopharmaceutical process applications while
delivering improved performance in a number of areas.
Fluid integrity is of crucial importance in many biopharmaceutical operations. Sani-Tech(...
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
... reduction of sugar in numerous product prototypes while
retaining the natural taste, as well as related en...uction of sweeteners in food and beverage products while
maintaining the desired sweet taste. Senomyx disc...ar in taste tests with numerous product prototypes while
maintaining the full sweet taste with no off-taste...
Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
...ime and difficulty of completing a wound closure in these types of surgical procedures, where tying sutures through small incisions using instruments, while
having limited visibility of patient anatomy, can be one of the most difficult and tedious aspects of such procedures for physicians. Patients may als...
Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit
...at physicians can offer their patients who are seeking a moisturizing agent while
using BenzaClin for their acne," says Brent Ragans, Vice President and Head of the General Therapeutics Business Unit, sanofi-aventis.
maintaining moisture can be a challenge for teens and young adults dealing ...
ETC Biomedical Announces Chamber Sale in India
...en therapy chamber. The BARA-MED features ETC's Smooth Ride(TM) technology while
helping our customers minimize oxygen consumption. The system will also in...liminate the need for operator dive time management and paper recordkeeping while
ensuring comprehensive documentation of the procedure. These features enabl...
OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
...ition will be operated by OmniComm's UK subsidiary, OmniComm Ltd.
Logos' exceptional software is used to collect clinical trial data gathered while
conducting Phase I clinical trials. Phase I clinical trials are the first stage of the US or International regulatory approval process, in order to g...
Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
... release dated August 3, 2009 incorrectly referred
to the Ministry of Health for the June 2009 order of four million
doses of Panflu. while
we may receive orders from the Ministry of
Health in the future, the June 2009 order was placed by the Beijing